Related Experiment Videos
A partially rigid butyrophenone analog with extended conformation
Die Pharmazie
|December 1, 1986
Summary
Researchers synthesized a new compound, 2-(2-Piperidinoethyl)-1-tetralone, which is a restricted analog of 4-piperidinobutyrophenone. This compound shows dopamine D2 receptor binding activity in vitro.
Area of Science:
- Medicinal Chemistry
- Neuropharmacology
- Organic Synthesis
Background:
- Dopamine D2 receptors are crucial targets in neuroscience.
- 4-Piperidinobutyrophenone analogs are investigated for their receptor interactions.
Purpose of the Study:
- To synthesize a conformationally restricted analog of 4-piperidinobutyrophenone.
- To evaluate the in vitro dopamine D2 receptor binding affinity of the synthesized compound.
Main Methods:
- Chemical synthesis of 2-(2-Piperidinoethyl)-1-tetralone.
- In vitro receptor binding assay using [3H]spiperone and rat striatal dopamine receptors.
Main Results:
- The synthesized compound, 2-(2-Piperidinoethyl)-1-tetralone, was successfully prepared.
- The compound demonstrated displacement of [3H]spiperone from dopamine D2 receptors.
- An IC50 value of 1.2 X 10(-4) mol/l was determined for the binding affinity.
Conclusions:
- The novel analog exhibits significant dopamine D2 receptor binding.
- Conformational restriction may influence receptor interaction profiles.